
15 segments available
American healthcare is in crisis—but what if we could change the system by preventing disease before it starts? In this episode of the a16z Podcast, general partner Vijay Pande sits down with Dr. Eric Topol, founder and director of the Scripps Research Translational Institute and one of the most cited researchers in medicine, to explore the cutting edge of preventive healthcare and longevity science. Drawing from his new book Super Agers: An Evidence-Based Path to Longevity, Topol breaks down why understanding the biology of aging—not reversing it—is the key to preventing the “Big Three” age-related diseases: cancer, cardiovascular disease, and neurodegenerative conditions. The conversation spans AI-powered risk prediction, organ clocks, polygenic risk scores, GLP-1s, and the cultural and economic shifts required to move from a “sick care” system to one rooted in precision prevention and extended health span. If you’ve ever wondered how data, personalized medicine, and AI can add seven healthy years to your life—and what it will take to bring those benefits to everyone—this episode is for you. Timecodes: 00:00 Introduction 00:39 Super Ages 02:05 Current State of American Healthcare 04:42 The Role of AI in Health 05:54 Revolutionary Advances in Immunotherapy 07:59 Beyond Diet and Exercise 08:54 The Impact of AI on Chronic Diseases 20:04 The Future of Preventive Healthcare Resources: Find Eric on X: https://x.com/erictopol Find Vijay on X: https://x.com/vijaypande Stay Updated: Let us know what you think: https://ratethispodcast.com/a16z Find a16z on Twitter: https://twitter.com/a16z Find a16z on LinkedIn: https://www.linkedin.com/company/a16z Subscribe on your favorite podcast app: https://a16z.simplecast.com/ Follow our host: https://x.com/eriktorenberg Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.
Dr. Eric Topol introduces the concept of preventing age-related diseases rather than reversing aging. He emphasizes the potential for adding seven healthy years to life by focusing on intelligent risk partitioning and the prevention of the 'Big Three' diseases: cancer, cardiovascular disease, and neurodegenerative conditions.
"American healthcare is in crisis. We have a path to prevention. It isn't reversing aging. It's just preventing the age related morbidities of the big three. It's been a fantasy for millennia. There sh..."
Dr. Topol shares the motivation for writing his book 'Super Agers,' discussing a significant study on aging and a remarkable patient who lived to 98 without ever being sick. He highlights the need for a deeper understanding of aging and the importance of addressing misconceptions in healthcare.
"So, you've written this really exciting book, Super Agers, an evidence-based path to longevity, and I think it's a very timely topic, and I was curious for you to maybe set the stage for why you wante..."
Topol discusses the current state of American healthcare, contrasting the focus on reversing aging with the need to prevent age-related diseases. He explains how understanding the biology of aging can lead to significant advancements in preventive healthcare.
"coming into a world where American healthcare is in crisis and I was curious to get your take on where we are now in in healthcare in the US and where do you think we could get to? Yeah. So there is t..."
In this segment, Dr. Topol elaborates on the preventability of cancer, cardiovascular disease, and neurodegenerative conditions. He emphasizes the role of lifestyle factors and the importance of understanding the biology of aging to mitigate these diseases.
"something that a lot of people may not realize is that the the big three that you mentioned, cancer, um heart disease, and Alzheimer's Alzheimer's and and dementia, uh that they're greatly exacerbated..."
Dr. Topol outlines the five dimensions of health, starting with the critical role of AI in integrating health data. He discusses how AI can analyze complex datasets to improve health outcomes and personalize medicine.
"you in your book outline the five dimensions of health. I was wondering maybe you could walk us through them. Yeah, sure. Sure. So the first most important one is AI because you need that to pull all ..."
Topol highlights groundbreaking advances in immunotherapy, including the use of personalized vaccines and the ability to reset the immune system. He shares examples of recent successes in treating autoimmune diseases and cancer.
"Could you give examples of that? Yeah. So in the last couple years we've seen unprecedented cures. We I mean never had anything. Lupus, progressive systemic sclerosis, even cases of multiple sclerosis..."
In this segment, Dr. Topol discusses the concept of 'lifestyle plus,' which encompasses a broader range of factors influencing health, including environmental burdens and time spent in nature. He emphasizes that preventing age-related diseases requires more than just diet and exercise.
"all this together, what does this mean for the individual? like how would their life change? What what should people be doing? Yeah. So I call it lifestyle plus it's a lot bigger than diet, sleep and ..."
Dr. Topol explains how AI can predict health outcomes based on historical data. He discusses the potential of using AI to forecast the onset of diseases like Alzheimer's and the importance of early intervention.
"coming into this because one of the things AI is very good at is to take a set of data and maybe you can mask out the last bit. So you can maybe have someone's health records over 30 years and train o..."
Topol clarifies the distinction between health span and life span, emphasizing the importance of living a healthy life free from major diseases. He discusses the implications of maintaining health as we age.
"important for people not familiar with the term of health span. That's basically not just lifespan, but how long you can be healthy. Yeah. I don't think we really want to get to some age and be dement..."
Dr. Topol addresses the impact of chronic diseases such as diabetes, heart disease, and cancer. He discusses the potential for using polygenic risk scores and early detection tests to make significant strides in cancer prevention.
"unanticipated is the glip one drugs uh the ozumpic you know uh zepbound world yes it's the most momentous drug class in medical history and we've only seen part of the story so far you know in the boo..."
In this segment, Topol discusses the revolutionary GLP-1 drugs and their unexpected benefits beyond diabetes management. He highlights their potential in reducing the risk of cancer and other chronic diseases.
"with pills that are remarkably effective to substitute for injections that can be much less expensively. Yes, that a large proportion of the population would be taking one of these drugs or even their..."
Dr. Topol explains the concept of organ clocks and how AI can help track the health of vital organs. He discusses the implications of this technology for personalized health assessments and interventions.
"time uh and and and not rebound. We don't have encouraging data at the moment because at least half of people gain weight back when they stop. Yeah. Uh and that's not good. But I do think that we'll c..."
Topol delves into the significance of molecular clocks in understanding aging and disease risk. He discusses how these tools can provide insights into individual health trajectories and inform preventive strategies.
"that's the case, what about your polygenic risk score? Is there anything pointing to that disease or organ? We can look at your whole body aging epigenetic Horvath clock. We can also look at specific ..."
Dr. Topol addresses the need for a shift in mindset among healthcare professionals from a reactive to a preventive approach. He emphasizes the importance of compelling data to support this transition.
"importantly, we have these organ clocks that are inexpensive to get. When you start having genes and proteins and these other layers of data, that's when you find out what is making us unique and what..."
In the concluding segment, Topol shares his vision for the future of preventive healthcare. He discusses the gradual shift towards healthier aging and the potential for countries to implement effective preventive strategies.
"example, speaking about waste, we do mass screening for cancer. We treat everyone uh as the same based on their age and that's the only criterion for screening, age. We only pick up 14% of cancers fro..."